RAS Clinical Trials

1 recruiting

RAS Trials at a Glance

314 actively recruiting trials for ras are listed on ClinicalTrialsFinder across 6 cities in 46 countries. The largest study group is Not Applicable with 117 trials, with the heaviest enrollment activity in Boston, New York, and Houston. Lead sponsors running ras studies include Tanta University, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and National Institute of Allergy and Infectious Diseases (NIAID).

Treatments under study

About RAS Clinical Trials

Looking for clinical trials for RAS? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new RAS trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about RAS clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 314 trials

Recruiting
Phase 1

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Endometrial CancerColorectal CarcinomaNon-small Cell Lung Cancer+3 more
AstraZeneca108 enrolled18 locationsNCT06218914
Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Phase 2

Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study

Weight GainHealthy VolunteerMetabolic Effects+1 more
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT05652478
Recruiting
Phase 1

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

KRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more
Kestrel Therapeutics, Inc.145 enrolled5 locationsNCT07458347
Recruiting

Host Response to Infection and Treatment in Filarial Diseases

HelminthiasisFilariasisParasitic Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)500 enrolled1 locationNCT00001230
Recruiting

dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound

Rheumatoid ArthritisInterstitial Lung DiseaseThoracic Ultrasound+1 more
University Hospital, Tours280 enrolled1 locationNCT06235645
Recruiting
Not Applicable

Sucrase-Isomaltase (SI) Genes and Meal Load

IBS - Irritable Bowel SyndromeSucrase-Isomaltase Deficiency
Region Skane70 enrolled1 locationNCT07309601
Recruiting
Not Applicable

The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.

ERASCesarean SectionBonding+1 more
Okan University1 enrolled1 locationNCT07276126
Recruiting
Not Applicable

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

SarcopeniaUltrasonographyAcute-On-Chronic Liver Failure+1 more
University Hospital, Antwerp20 enrolled1 locationNCT06079021
Recruiting
Not Applicable

Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II

PrehabilitationFrail ElderlyLumbar Degenerative Disease+2 more
Xuanwu Hospital, Beijing248 enrolled4 locationsNCT07396077
Recruiting
Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
UConn Health10 enrolled1 locationNCT06846853
Recruiting

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

Immune System DiseasesEosinophiliaHelminthiasis+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001406
Recruiting
Not Applicable

Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis

EndometriomaQuality of LifeUltrasound Therapy; Complications+1 more
Hospital Universitari de Bellvitge288 enrolled28 locationsNCT06955221
Recruiting
Not Applicable

Point-of-care Ultrasound Utility in the Free Clinic Setting

Point of Care Ultrasound (POCUS)
Indiana University50 enrolled1 locationNCT07556341
Recruiting
Phase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Ras-mutated Metastatic Colorectal Cancer
Oncolytics Biotech60 enrolled1 locationNCT07446322
Recruiting

Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries

Ovarian CancerBRCA MutationUltrasound Therapy; Complications
Fondazione Policlinico Universitario Agostino Gemelli IRCCS6,465 enrolled1 locationNCT05769517
Recruiting

Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

Trastuzumab EmtansineCancer of BreastTrastuzumab Deruxtecan
Seoul National University Hospital100 enrolled1 locationNCT06928818
Recruiting

Comparison of Two Airway Devices (I-Gel and Air-Q) in Children Aged 1-10 Years During General Anesthesia

UltrasonographyAirway ManagementChild+2 more
Ankara Etlik City Hospital60 enrolled1 locationNCT07522957
Recruiting
Not Applicable

Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer

UltrasoundOropharyngeal Carcinoma
Tobias Todsen180 enrolled4 locationsNCT07548268
Recruiting
Phase 1

TLN-372 in Advanced KRAS Mutant Solid Tumors

KRAS Mutant Solid Tumors
Treeline Biosciences, Inc.240 enrolled11 locationsNCT07204340